Entero Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2015 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Entero Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2015 to Q1 2024.
  • Entero Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending March 31, 2024 was 2.03M shares, a 30.7% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 2.03M +476K +30.7% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.56M +1.51M +3038% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 13.5M +12.5M +1253% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 4.21M +3.21M +323% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 1.55M -20M -92.8% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 49.8K -21K -29.7% Dec 31, 2022 10-K 2024-03-29
Q3 2022 995K -10.1M -91% Sep 30, 2022 10-Q 2023-11-13
Q2 2022 995K -81.6M -98.8% Jun 30, 2022 10-Q 2023-08-14
Q1 2022 21.5M -53.4M -71.2% Mar 31, 2022 10-Q 2022-05-23
Q4 2021 70.7K -3.04M -97.7% Dec 31, 2021 10-K 2023-03-20
Q3 2021 11.1M -17.8M -61.5% Sep 30, 2021 10-Q/A 2021-11-16
Q2 2021 82.6M +54.1M +190% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 74.9M +47.8M +176% Mar 31, 2021 10-Q 2021-05-24
Q4 2020 3.12M -23.7M -88.4% Dec 31, 2020 10-K 2022-03-31
Q3 2020 28.9M 0 0% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 28.5M +7.4M +35.1% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 27.2M +8.62M +46.5% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 26.8M +9.1M +51.4% Dec 31, 2019 10-K 2021-03-31
Q3 2019 28.9M +11.9M +70.5% Sep 30, 2019 10-Q 2020-11-16
Q2 2019 21.1M +4.31M +25.7% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 18.5M +5.94M +47.1% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 17.7M +5.66M +47% Dec 31, 2018 10-K 2020-03-30
Q3 2018 16.9M +5.52M +48.3% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 16.8M +5.67M +51% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 12.6M Mar 31, 2018 10-Q 2018-05-14
Q4 2017 12M +7.75M +180% Dec 31, 2017 10-K 2019-04-01
Q3 2017 11.4M +5.39M +89.4% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 11.1M Jun 30, 2017 10-Q 2017-08-14
Q4 2016 4.3M 0 0% Dec 31, 2016 10-K 2018-03-16
Q3 2016 6.03M Sep 30, 2016 10-Q 2016-11-25
Q4 2015 4.3M Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.